cilostazol has been researched along with Glaucoma in 1 studies
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the pharmacological properties of cilostazol (CLZ), we examined its intraocular pressure (IOP) -lowering effect." | 7.76 | Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea. ( Ito, Y; Kurimoto, T; Mimura, O; Murao, T; Nagai, N; Okamoto, N; Takiguchi, Y, 2010) |
| "To evaluate the pharmacological properties of cilostazol (CLZ), we examined its intraocular pressure (IOP) -lowering effect." | 3.76 | Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea. ( Ito, Y; Kurimoto, T; Mimura, O; Murao, T; Nagai, N; Okamoto, N; Takiguchi, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, N | 1 |
| Ito, Y | 1 |
| Nagai, N | 1 |
| Murao, T | 1 |
| Takiguchi, Y | 1 |
| Kurimoto, T | 1 |
| Mimura, O | 1 |
1 other study available for cilostazol and Glaucoma
| Article | Year |
|---|---|
Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Animals; Antihypertensive Agents; beta-Cyclodextrins; | 2010 |